Our Pricing

Wegovy 1mg UK Online Pharmacy — In Stock Today

Finding a reliable wegovy 1mg uk online pharmacy with immediate stock availability can be challenging during ongoing supply constraints. At Cured Pharmacy, we maintain consistent Wegovy 1mg supplies with transparent pricing from £79.00 free clinical consultations under three minutes, and next-day discreet delivery across the UK.

Why Wegovy 1mg Is the Most Prescribed Weight Loss Injection in the UK

Wegovy 1mg represents the maintenance dose in a carefully structured titration programme designed to optimise tolerability whilst maximising weight loss outcomes. The active ingredient, semaglutide, is a GLP-1 receptor agonist that mimics a natural gut hormone to reduce appetite, slow gastric emptying, and improve glycaemic control [1].

In the landmark STEP 1 trial involving 1,961 adults with obesity, participants using semaglutide 2.4mg (the target dose reached through 1mg escalation) achieved an average 14.9% body weight reduction over 68 weeks, compared to 2.4% with placebo [1]. Importantly, 86.4% of participants in the semaglutide group lost at least 5% of their baseline weight — the threshold associated with meaningful metabolic improvements [2].

The 1mg dose serves as a critical stepping stone in this titration schedule, typically administered during weeks 13-16 of treatment before progressing to the full 2.4mg maintenance dose. This graduated approach significantly reduces the incidence of gastrointestinal side effects that can occur when GLP-1 receptor agonists are introduced too rapidly [3].

Understanding the Wegovy Dosing Schedule: Where 1mg Fits

Wegovy follows a five-stage dose escalation protocol mandated by the MHRA to balance efficacy with tolerability. Patients begin at 0.25mg weekly for four weeks, then progress through 0.5mg, 1mg, and 1.7mg before reaching the 2.4mg maintenance dose at week 17.

The 1mg dose phase typically lasts four weeks and represents the point where many patients begin experiencing substantial appetite suppression and weight loss acceleration. Clinical data shows that gastrointestinal side effects — primarily nausea, diarrhoea, and constipation — peak during the escalation phases but generally resolve as the body adapts to each new dose level [3].

Our superintendent pharmacist Tarun Kumar notes that patients who experience persistent side effects at 1mg may benefit from extending this dose phase by an additional 2-4 weeks before progressing, though any dosing adjustments must be made under prescriber guidance.

What Happens If You Miss the 1mg Dose Phase?

Skipping dose escalation steps or rushing through the titration schedule increases the risk of intolerable side effects that may lead to treatment discontinuation. If you miss a scheduled 1mg injection and it's been less than five days, administer the dose as soon as you remember. If more than five days have passed, skip that dose and resume your regular schedule with the next planned injection. Never double doses to compensate for missed injections.

Wegovy 1mg vs Other Semaglutide Doses: Clinical Differences

Whilst Wegovy 1mg is part of a titration sequence rather than a standalone maintenance dose, understanding how different semaglutide concentrations compare helps contextualise your treatment journey. Lower doses (0.25mg and 0.5mg) primarily serve to build physiological tolerance, whilst the 1mg dose begins delivering measurable weight loss outcomes in most patients.

Comparative analysis from the STEP trials demonstrates a clear dose-response relationship with semaglutide. Participants who reached and maintained the full 2.4mg dose experienced significantly greater weight reduction than those on lower maintenance doses, though even submaximal doses produced clinically meaningful results [2].

It's worth noting that Ozempic, another semaglutide product, is licensed for type 2 diabetes management at doses up to 1mg weekly. Whilst chemically identical to Wegovy's active ingredient, Ozempic is not licensed for weight management in the UK, and using diabetes medications off-label for weight loss raises both regulatory and supply chain concerns that impact patients who depend on these medicines for glycaemic control [4].

Why Wegovy Requires Prescription-Only Access

Semaglutide carries specific contraindications including personal or family history of medullary thyroid carcinoma, multiple endocrine neoplasia syndrome type 2, and severe gastrointestinal disease. A thorough clinical assessment by a UK-registered prescriber ensures the medication is both safe and appropriate for your individual circumstances. At Cured Pharmacy, this assessment is completed online in under three minutes, with same-day prescriber review in most cases.

How to Order Wegovy 1mg from Cured Pharmacy

Our streamlined process eliminates waiting lists whilst maintaining full clinical governance. Start by completing a brief online consultation covering your medical history, current medications, and weight loss goals. Our UK-registered prescribers review every submission individually — typically within hours during business days.

If approved, your prescription is sent directly to our GPhC-registered dispensary where our pharmacy team prepares your order with 100% discreet packaging. We dispatch via next-day tracked courier to any UK address, with weekend and evening delivery slots available for added convenience.

Pricing is transparent from the outset: Wegovy 1mg pens start from £79.00 with the exact cost confirmed before you complete your consultation. There are no hidden fees, no subscription lock-ins, and no pressure to commit beyond your current prescription cycle. You'll always know what you're paying before any clinical assessment begins.

Managing Side Effects During the 1mg Dose Phase

Gastrointestinal symptoms remain the most commonly reported side effects during Wegovy titration, affecting up to 44% of patients in clinical trials [3]. These typically manifest as mild to moderate nausea, occasional vomiting, diarrhoea, or constipation, and generally diminish within 2-3 weeks as your body adapts to each new dose.

Practical strategies to minimise discomfort include eating smaller, more frequent meals rather than large portions, avoiding high-fat foods that slow digestion further, and staying well-hydrated throughout the day. Some patients find that administering their injection in the evening reduces daytime nausea, though you should maintain a consistent injection day and time once established.

Severe or persistent side effects warrant immediate prescriber contact. Symptoms such as severe abdominal pain, persistent vomiting preventing fluid intake, signs of pancreatitis, or allergic reactions require urgent medical assessment. Our clinical team remains available via phone on (+44) 116 4646009 during business hours for any concerns during your treatment journey.

When to Contact Your Prescriber

Reach out if you experience side effects that interfere with daily activities, if you're unable to progress to the next dose due to tolerability issues, or if you have questions about injection technique. Early intervention often prevents treatment discontinuation and helps optimise your individual dosing schedule.

Wegovy 1mg Availability and UK Supply Situation

Semaglutide-based weight loss treatments have experienced unprecedented demand across Europe since 2022, leading to intermittent supply constraints at various dose strengths. Manufacturer Novo Nordisk has prioritised production scale-up, and UK supplies have stabilised considerably throughout 2024.

At Cured Pharmacy, we maintain direct relationships with licensed UK wholesalers and implement robust stock management protocols to ensure consistent availability across all Wegovy dose strengths, including the 1mg pens. Our 'no waiting list' commitment means that when you complete your consultation and receive prescriber approval, your medication ships within one business day.

We monitor MHRA supply notifications continuously and proactively communicate with patients if any supply disruptions are anticipated. Unlike some providers who accept consultations regardless of stock status, we only process clinical assessments when we have confirmed inventory to fulfil approved prescriptions immediately. This approach respects both your time and clinical needs, ensuring you can progress through your titration schedule without interruption.

Scientific References

1. Wilding, J. P. H., et al. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine, 384(11), 989–1002. https://doi.org/10.1056/NEJMoa2032183
2. Rubino, D., et al. (2021). Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance in Adults With Overweight or Obesity: The STEP 4 Randomized Clinical Trial. JAMA, 325(14), 1414–1425. https://doi.org/10.1001/jama.2021.3224
3. Garvey, W. T., et al. (2022). Two-year effects of semaglutide in adults with overweight or obesity: the STEP 5 trial. Nature Medicine, 28(10), 2083–2091. https://doi.org/10.1038/s41591-022-02026-4
4. Medicines and Healthcare products Regulatory Agency. (2023). Semaglutide (Wegovy) for weight management: reminder about appropriate use and supply issues. Drug Safety Update, 16(9). https://www.gov.uk/drug-safety-update

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication. Wegovy is indicated for weight management in adults with a BMI ≥30 kg/m², or ≥27 kg/m² with at least one weight-related comorbidity, alongside a reduced-calorie diet and increased physical activity.